| Doomernik, Chris (Health Valley Netherlands 202009 Managing Director) |
Managing Director |
Health Valley Netherlands |
Netherlands |
| Dootson, John (Cyprotex 201608 CFO) |
Chief Financial Officer (CFO) |
Evotec (Group) |
United Kingdom (GB) |
| Doppler, Clemens (3i Germany 2007 Director Healthcare Team) |
Investment Manager |
3i (Group) |
Germany |
| Dorigatti, Roberto (Evotec 201803 SVP Integrated Development Programmes) |
President/Director/Head Business Group/Unit/Division |
Evotec (Group) |
Germany |
| Dormann, Jürgen |
Chief Executive Officer (CEO) |
Sanofi (Group) [since May 2011] |
Germany |
| Dorn, Ingmar (Bayer Technology Services GmbH 200503) |
n. a. |
Bayer (Group) |
Germany |
| Dornheim, Matthias (VWR International 200809) |
n. a. |
Avantor (Group) |
Germany |
| Doron, Yossi (BioTag Ltd 201302 Business Development Manager) |
Business Development Manager / Strategy Manager |
BioTag Ltd. |
Israel |
| Dorrepaal, Karin Louise (Schering 200602) |
n. a. |
Bayer (Group) |
Germany |
| Dorrestein, Pieter C. (Univ California San Diego 201201 Chemistry Faculty) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
University of California, San Diego, Dorrestein Lab |
United States (USA) |
| Dorsch, Katharina (Gimv 2016– Associate Health & Care team in Munich= |
n. a. |
Gimv (Group) |
Germany |
| Dorsey, Brian T. (MagnaSci Ventures 201704 Founding Partner) |
Managing Partner (investment firm) |
MagnaSci Ventures |
United States (USA) |
| Dorton, Katina (AvroBio 201709– CFO before Immatics + Needham & Co + Morgan Stanley + Sullivan & Chromwell) |
Chief Financial Officer (CFO) |
AvroBio (Group) |
United States (USA) |
| Dosch, Dominik (Max Planck 201207 MPI for Biochemistry Protein Analytics) |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
| Dossetter, Alexander (MedChemica Ltd 201306 Managing Director + Founder before AstraZeneca) |
Managing Director |
MedChemica Ltd. |
United Kingdom (GB) |
| Dostatni, Ralf (Milenia Biotec GmbH 201110 Managing Director) |
Managing Director |
Milenia Biotec GmbH |
Germany |
| Doudna, Jennifer (Univ California Berkeley 201412) |
Researcher (university / research institute) |
University of California (System) |
United States (USA) |
| Dougherty, James B. (Arcus Ventures 2007– General Partner + Co-founder) |
General Partner (venture partner) |
Arcus Ventures |
United States (USA) |
| Douglas, James (Exonhit– VP 200801 Corp Developm before Epigenomics 200601–200712 before Biosite) |
Business Development Manager / Strategy Manager |
Diaxonhit (Group) |
France |
| Dowdeswell, Christian (Lonza 201902 Head Dosage Forms + Delivery Systesm at Lonza Pharma & Biotech) |
President/Director/Head Business Group/Unit/Division |
Lonza (Group) |
Switzerland |
| Dowe, Tanja (Debiopharm 201705 Head of Debiopharm Innovation Fund) |
Investment Manager |
Debiopharm (Group) |
Switzerland |
| Doyle, Laurie (MC Services 201707 US) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Doyle, Stephen (Aslan Pharmaceuticals 202103 CBO before Boehringer Ingelheim + Sanofi) |
Chief Business Officer (CBO) |
Aslan Pharmaceuticals Ltd. (Nasdaq: ASLN) |
Singapore |
| Draetta, Francesco (Omega Funds 202010 Principal) |
Principal (venture capital) |
Omega Funds (Group) |
United States (USA) |
| Draheim, Henning (Boehringer Ingelheim 201111) |
Researcher (industry) |
Boehringer Ingelheim (Group) |
Germany |
| Drake, Richard (Medical Univ of South Carolina 201905 Professor + Director of Proteomics Center) |
Professor |
Medical University of South Carolina |
United States (USA) |
| Dranoff, Glenn (Novartis 201503– Head of new Immuno-oncology Research Group before Dana Farber) |
Researcher (industry) |
Novartis (Group) |
Switzerland |
| Drees, Ulrich (Boehringer Ingelheim 201301 Corporate SVP International Project Management) |
President/Director/Head Business Group/Unit/Division |
Boehringer Ingelheim (Group) |
Germany |
| Dreher, Christian (R-Biopharm 201907 CEO) |
Chief Executive Officer (CEO) |
R-Biopharm (Group) |
Germany |
| Dreher, Ralf (R-Biopharm 201111 CEO) |
Chief Executive Officer (CEO) |
R-Biopharm (Group) |
Germany |
| Dreiling, Thomas (Creathor Ventures 2017– PR + Communications before MSLGroup) |
Public Relations Manager / Investor Relations Manager |
Creathor Ventures (Group) |
Germany |
| Dreisewerd, Klaus (Univ Münster 201606 Professor) |
Professor |
University of Münster (Westfälische Wilhelms-Universität Münster) |
Germany |
| Dreismann, Heiner (GeneNews 200810 Interim CEO + Lead Director before Roche Molecular Diagnostic CEO) |
Chief Executive Officer (CEO) |
GeneNews Ltd. (TSX: GEN) |
Canada |
| Drejer, Kirsten (Symphogen 2000–201608 Founding CEO since 201609 Executive Director) |
Board member, executive |
Servier (Group) |
Denmark |
| Drescher, Thomas (DASGIP AG 201201 CEO) |
Chief Executive Officer (CEO) |
Eppendorf (Group) |
Germany |
| Dreusch, Andrea B. (Micromol GmbH 201110 Managing Director) |
Managing Director |
Micromol GmbH |
Germany |
| Dreusch, Andreas H.-J. (Micromol GmbH 201110 Managing Director) |
Managing Director |
Micromol GmbH |
Germany |
| Drexhage, Karl H. (Atto-Tec 1999–) |
n. a. |
Atto-Tec GmbH |
Germany |
| Drexler, Mathias (ACIB GmbH 201108 Managing Director) |
Managing Director |
ACIB GmbH – Austrian Centre of Industrial Biotechnology |
Austria |
| Driesen, Guido (Lonza 201612 CEO of Capsugel) |
Chief Executive Officer (CEO) |
Lonza (Group) |
United States (USA) |
| Driess, Matthias (TU Berlin 201008 Professor Dept of Chemistry) |
Professor |
Technical University Berlin (TU Berlin) |
Germany |
| Drijver, Alex (ChemAxon 200805 CEO before ThalesNano CEO + CFO before ComGenex CFO) |
Chief Executive Officer (CEO) |
ChemAxon (Group) |
Hungary |
| Dro, Philippe (LimmaTech Biologics 201505– before GlycoVaxyn CEO) |
Chief Executive Officer (CEO) |
LimmaTech Biologics AG |
Switzerland |
| Droller, Rémi (Kurma 201305 Managing Partner at Kurma Life Sciences Partners) |
Managing Partner (investment firm) |
Eurazeo (Group) |
France |
| Dromey, James (Murdochs Children Research Institute 201404 Head of Commercialisation) |
Sales Manager / Marketing Manager |
Murdoch Childrens Research Institute (MCRI) |
Australia |
| Dropulic, Boro (Lentigen 200601 Founder + CEO) |
Chief Executive Officer (CEO) |
Opus Bio Inc. |
United States (USA) |
| Drouet, Philippe (CRISPR Therapeutics 202102– Chief Commerical Officer before Merck & Co + Hospira + Novartis) |
Chief Commercial Officer (CCO) |
CRISPR Therapeutics (Group) |
Switzerland |
| Drumm, Joshua (Valneva 202108 VP Global Investor Relations before AC Immune) |
Public Relations Manager / Investor Relations Manager |
Valneva (Group) |
France |
| du Buman, Jean-Luc (SGS 201609 Corp Developm + Communications + PR) |
Public Relations Manager / Investor Relations Manager |
SGS (Group) |
Switzerland |
| Dubilier, Nicole (Max Planck 201309– Director of MPI Bremen + Prof at Univ Bremen) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
| Dubourg, Saori (BASF 201909 Executive Board Director) |
Board member, executive |
BASF (Group) |
Germany |
| Dubro, Claudia (Brandenburg (govt) 201912 Investment Manager at Brandenburg Kapital GmbH) |
Investment Manager |
Brandenburg (govt region) |
Germany |
| Dubruel, Gauthier (UbiSim 202110 Co-Founder) |
Company Founder |
Labster (Group) |
Switzerland |
| Dubruque, Samuel (Global Bioenergies 201710– CFO joined 2013 before Suez + Total) |
Chief Financial Officer (CFO) |
Global Bioenergies (Group) |
France |
| Dubuis, Benoît (Campus Biotech Geneva 201601 Site Director) |
President/Director/Head Business Group/Unit/Division |
Campus Biotech Innovation Center (Geneva, former Merck Serono site) |
Switzerland |
| Dubuis, Olivier (Viollier 201106) |
n. a. |
Viollier AG |
Switzerland |
| Duchemin, Jeffrey A. (Harvard Bioscience 201410 CEO) |
Chief Executive Officer (CEO) |
Harvard Bioscience (Group) |
United States (USA) |
| Duchesne de Lamotte, Hervé (ExonHit 200911– CFO before Cirrus Finance Management before IDM Paris) |
Chief Financial Officer (CFO) |
Diaxonhit (Group) |
France |
| Duci, Barbara (Evolva 202103 Head of Investor + Corporate Relations) |
Public Relations Manager / Investor Relations Manager |
Evolva (Group) |
Switzerland |
| Ducrey, Bertrand (Debiopharm 201610 CEO of Debiopharm International) |
Chief Executive Officer (CEO) |
Debiopharm (Group) |
Switzerland |
| Duda, Maria (Genome Biologics (DE) 201810 Head of Business Development) |
Business Development Manager / Strategy Manager |
Genome Biologics UG |
Germany |
| Dufour, Sandrine (UCB 202007– CFO before Proximus + Vivendi + SFR) |
Chief Financial Officer (CFO) |
UCB (Group) |
Belgium |
| Dufresne, Claude (AxiVend LLC 201909 before Scienion) |
Chief Business Officer (CBO) |
AxiVend LLC |
United States (USA) |
| Dugi, Klaus (Boehringer 201106 Corporate SVP Medicine) |
Chief Medical Officer (CMO) |
Boehringer Ingelheim (Group) |
Germany |
| Duhr, Stefan (NanoTemper 201410 Managing Director + Co-founder) |
Managing Director |
NanoTemper (Group) |
Germany |
| Dulac, Emmanuel (Zealand Pharma 201909–202203 CEO LEFT 3/22) |
Chief Executive Officer (CEO) |
Zealand Pharma (Group) |
Denmark |
| Dumitraskovic, Marion (Medicyte GmbH 201302 Sales + Marketing Manager) |
Sales Manager / Marketing Manager |
Medicyte GmbH |
Germany |
| Dumont, Jean-Maurice (Debiopharm 201504 VP Medical Affairs) |
Chief Medical Officer (CMO) |
Debiopharm (Group) |
Switzerland |
| Dunant, Nicolas (Roche 202002 Head Media Relations) |
Public Relations Manager / Investor Relations Manager |
Roche (Group) |
Switzerland |
| Duncan, Carri (Celyad 201810– VP CorpDev + Communications before Bayer + Egon Zehnder + Credit Suisse + Novartis) |
Business Development Manager / Strategy Manager |
Celyad (Group) |
Belgium |
| Dunlay, R. Terry (IntelliCyt 2016 CEO + Founder) |
Chief Executive Officer (CEO) |
Sartorius (Group) |
United States (USA) |
| Duntze, Sabine (B3C Group GmbH 201104 Managing Director) |
Managing Director |
B3C Group GmbH |
Switzerland |
| Dupont-Inglis, Joanna (EuropaBio 201809– Secretary General) |
lobbying |
EuropaBio aisbl – the European Association of Bioindustries |
Belgium |
| Durack, Gary (iCyt 201002–<201206 CEO + Founder LEFT before 6/12) |
Chief Executive Officer (CEO) |
Sony (Group) |
United States (USA) |
| Durán, Cristina (AstraZeneca 201302– CFO at AstraZeneca GmbH before Finance Director at headquarters) |
Chief Financial Officer (CFO) |
AstraZeneca (Group) |
Germany |
| Durand, Nicolas (Abionic 201604 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Abionic S.A. |
Switzerland |
| Durano, Jean-Marc (Meriéux 201106 Corporate VP Industrial Microbiology at bioMérieux) |
President/Director/Head Business Group/Unit/Division |
Mérieux (Group) |
France |
| Durdy, Matthew (United Kingdom (govt) 2020– CEO of Cell and Gene Therapy Catapult before CBO joined 2012) |
Chief Executive Officer (CEO) |
United Kingdom (GB) (govt) |
United Kingdom (GB) |
| Durham, Lynn (Stalicla 2017– CEO + Founder) |
Chief Executive Officer (CEO) |
Stalicla S.A. |
Switzerland |
| Durinx, Christine (VIB 202204– Co-Managing Director before Swiss Institute of Bioinformatics Executive Director) |
Managing Director |
Swiss Institute of Bioinformatics (SIB) |
Switzerland |
| Durner, Roland (Tecan 200711 Market Manager) |
Sales Manager / Marketing Manager |
Tecan (Group) |
Switzerland |
| Durst, Roger (Bruker Corp 201512 CTO + General Manager of Crystallography at Bruker AXS) |
Chief Technology/Technical Officer (CTO) |
Bruker (Group) |
Germany |
| Dusek, Alex (Erytech 201805– VP Commercial Strategy before Argos Therapeutics + Bayer HealthCare + United Therapeutics) |
Business Development Manager / Strategy Manager |
Erytech (Group) |
United States (USA) |
| Duss, Jonas (Kaia Health 202012 US CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Kaia Health (Group) |
United States (USA) |
| Duvall, Jean (Ferring 201912 Executive Board Member of Ferring Pharmaceuticals + Co-Chair of FerGene) |
Board member, executive |
Ferring (Paulsen Foundation) (Group) |
Switzerland |
| Dübel, Stefan (TU Braunschweig 201912 Professor for Biotechnology) |
Professor |
Technical University Braunschweig (TU Braunschweig) |
Germany |
| Düchting, Matthias (Hamilton Robotics 200704 International Sales Director) |
Sales Manager / Marketing Manager |
Hamilton (Group) |
Switzerland |
| Dyck, Joachim (Yaya Diagnostics 201311– Managing Director before AnagnosTec + Chimera Biotec) |
Managing Director |
Yaya Diagnostics GmbH |
Germany |
| Dyer, Tim (Addex CEO 201802 formerly CFO + Co-Founder) |
Chief Executive Officer (CEO) |
Addex (Group) |
Switzerland |
| Dylan-Hyde, Tyler (CRISPR Therapeutics 201703 Chief Legal Officer) |
General Counsel / Chief Legal Officer (CLO) |
CRISPR Therapeutics (Group) |
Switzerland |
| Düllmann, Peter (Sal. Oppenheim 200305–200809– Analyst) |
Analyst (Financial / Industry) |
Sal. Oppenheim (Group) |
Germany |
| Dymaszewski, Claudia (Caliper Life Sciences 200809 Caliper Germany) |
Sales Manager / Marketing Manager |
BioFluidix GmbH |
Germany |
| Dünwald, Christoph (Biofrontera 201511– CCO before Allergan + Corporacion Dermoestetica + Bayer) |
Chief Commercial Officer (CCO) |
Biofrontera (Group) |
Germany |
| Dyrberg, Thomas (Novo 201105 Senior Partner Novo Ventures) |
Partner (venture partner) |
Novo Group (Group) |
Denmark |
| Dürre, Thomas (ITM Isotopen Technologien München 202104 CFO) |
Chief Financial Officer (CFO) |
ITM (Group) |
Germany |
| Düx, Petra |
n. a. |
Berlin (govt region) |
Germany |
| Däbritz, Frank (UGA Biopharma GmbH 201708 Marketing + Sales) |
Sales Manager / Marketing Manager |
UGA Biopharma GmbH |
Germany |
| Dähne, Lars (Surflay Nanotec GmbH 201008– Managing Director + Founder before 200803 Project Manager at Capsulution) |
Managing Director |
Capsulution (Group) |
Germany |
| Däweritz, Carsten (Evolva 202104 CFO before almost 20y at Lonza) |
Chief Financial Officer (CFO) |
Evolva (Group) |
Switzerland |
| Döbelin, Werner (Prolab GmbH 199605– Managing Director + Founder + Owner) |
Managing Director |
Bruker (Group) |
Switzerland |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
![Picture [iito] Life Science Business Portals Media Data 2022 2 650x100px](/banner/iito-business-intelligence-20220406-650-100-promote-brand-to-decision-makers.jpg)
1 2 3 ... 15 16 17 ... 79 80 81 
![Picture [iito] Fighting Customers 650x100px](/banner/iito-business-intelligence-20211013-650-100-summer-banner-series-fighting-customers.jpg)
![Picture [iito] [LSE] Life-Sciences-Europe.com Business Portal 650x300px](/banner/iito-business-intelligence-20220406-650-300-lse-life-sciences-europe.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSE] Life-Sciences-Europe.com – The Business Web Portal 120x600px](/banner/iito-20150801-120-600-lse-life-sciences-europe-com.jpg)
